Bamco Inc. NY Increases Stake in Novanta Inc. $NOVT

Bamco Inc. NY boosted its stake in shares of Novanta Inc. (NASDAQ:NOVT) by 49.4% in the 4th quarter, Holdings Channel reports. The fund owned 936,962 shares of the technology company’s stock after buying an additional 309,869 shares during the period. Bamco Inc. NY’s holdings in Novanta were worth $111,489,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors also recently bought and sold shares of the stock. American Capital Management Inc. raised its position in Novanta by 74.5% during the fourth quarter. American Capital Management Inc. now owns 381,866 shares of the technology company’s stock valued at $45,438,000 after acquiring an additional 163,005 shares in the last quarter. Polar Asset Management Partners Inc. raised its position in Novanta by 0.7% during the fourth quarter. Polar Asset Management Partners Inc. now owns 42,014 shares of the technology company’s stock valued at $4,999,000 after acquiring an additional 294 shares in the last quarter. AQR Capital Management LLC raised its position in Novanta by 1,345.9% during the fourth quarter. AQR Capital Management LLC now owns 170,692 shares of the technology company’s stock valued at $20,311,000 after acquiring an additional 158,887 shares in the last quarter. Lazard Asset Management LLC raised its position in Novanta by 12.5% during the fourth quarter. Lazard Asset Management LLC now owns 3,869 shares of the technology company’s stock valued at $460,000 after acquiring an additional 431 shares in the last quarter. Finally, DF Dent & Co. Inc. raised its position in Novanta by 59.3% during the fourth quarter. DF Dent & Co. Inc. now owns 467,719 shares of the technology company’s stock valued at $55,654,000 after acquiring an additional 174,044 shares in the last quarter. 98.35% of the stock is currently owned by hedge funds and other institutional investors.

Novanta Stock Down 2.4%

Novanta stock opened at $151.43 on Thursday. The stock has a market capitalization of $5.39 billion, a PE ratio of 109.73 and a beta of 1.68. Novanta Inc. has a 12 month low of $98.27 and a 12 month high of $171.85. The business has a 50 day simple moving average of $145.35 and a 200-day simple moving average of $133.73. The company has a debt-to-equity ratio of 0.15, a current ratio of 3.56 and a quick ratio of 2.69.

Novanta (NASDAQ:NOVT) last posted its quarterly earnings data on Monday, May 11th. The technology company reported $0.81 EPS for the quarter, beating analysts’ consensus estimates of $0.78 by $0.03. The business had revenue of $257.71 million during the quarter, compared to analysts’ expectations of $253.40 million. Novanta had a return on equity of 12.06% and a net margin of 5.35%.The business’s revenue was up 10.4% compared to the same quarter last year. During the same period in the previous year, the business earned $0.74 earnings per share. Novanta has set its FY 2026 guidance at 3.500-3.650 EPS and its Q2 2026 guidance at 0.810-0.860 EPS. On average, analysts anticipate that Novanta Inc. will post 3.59 EPS for the current fiscal year.

Wall Street Analyst Weigh In

Several brokerages recently weighed in on NOVT. Wall Street Zen cut Novanta from a “buy” rating to a “hold” rating in a research report on Saturday, April 18th. Robert W. Baird set a $180.00 price objective on Novanta in a research report on Tuesday, June 9th. Finally, Weiss Ratings restated a “hold (c-)” rating on shares of Novanta in a research report on Friday, April 17th. One research analyst has rated the stock with a Buy rating and two have assigned a Hold rating to the stock. Based on data from MarketBeat, Novanta currently has an average rating of “Hold” and a consensus price target of $180.00.

Insider Activity at Novanta

In other news, CEO Matthijs Glastra sold 7,500 shares of the business’s stock in a transaction that occurred on Tuesday, May 12th. The stock was sold at an average price of $150.43, for a total value of $1,128,225.00. Following the completion of the sale, the chief executive officer directly owned 42,761 shares in the company, valued at $6,432,537.23. The trade was a 14.92% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 1.20% of the stock is owned by company insiders.

About Novanta

Novanta, Inc (NASDAQ: NOVT) is a global technology company that designs and manufactures precision components, subsystems and software used in advanced photonics and motion control applications. The company serves customers in the medical device and advanced industrial markets, supplying critical technologies for diagnostics and therapeutic systems, semiconductor and electronics manufacturing, and scientific instrumentation. Novanta’s product portfolio includes laser control modules, optics, beam delivery systems, high-precision motors, actuators, stages, and fluidics solutions designed to meet stringent accuracy and reliability requirements.

Novanta’s Photonics segment delivers laser and energy delivery components that enable minimally invasive surgical procedures and diagnostic imaging.